[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PML-1; PML-2 AND PML-3), AND CHROMOSOMAL TRANSLOCATION WITH RARA.
PubMed=1720570 [NCBI, ExPASy, EBI, Israel, Japan]
Goddard A.D.,
Borrow J.,
Freemont P.S.,
Solomon E.;
"Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.";
Science 254:1371-1374(1991).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-X).
PubMed=1311253 [NCBI, ExPASy, EBI, Israel, Japan]
Kastner P.,
Perez A.,
Lutz Y.,
Rochette-Egly C.,
Gaub M.P.,
Durand B.,
Lanotte M.,
Berger R.,
Chambon P.;
"Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.";
EMBO J. 11:629-642(1992).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-3B).
DOI=10.1016/0092-8674(91)90112-C; PubMed=1652368 [NCBI, ExPASy, EBI, Israel, Japan]
Kakizuka A.,
Miller W.H. Jr.,
Umenono K.,
Warrell R.P. Jr.,
Frankel S.R.,
Murty V.V.,
Dmitrovsky E.,
Evans R.M.;
"Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.";
Cell 66:663-674(1991).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-3B).
Goddard A.D.,
Solomon E.;
Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-1).
DOI=10.1093/emboj/20.9.2140; PubMed=11331580 [NCBI, ExPASy, EBI, Israel, Japan]
Reymond A.,
Meroni G.,
Fantozzi A.,
Merla G.,
Cairo S.,
Luzi L.,
Riganelli D.,
Zanaria E.,
Messali S.,
Cainarca S.,
Guffanti A.,
Minucci S.,
Pelicci P.G.,
Ballabio A.;
"The tripartite motif family identifies cell compartments.";
EMBO J. 20:2140-2151(2001).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04601; PubMed=16572171 [NCBI, ExPASy, EBI, Israel, Japan]
Zody M.C.,
Garber M.,
Sharpe T.,
Young S.K.,
Rowen L.,
O'Neill K.,
Whittaker C.A.,
Kamal M.,
Chang J.L.,
Cuomo C.A.,
Dewar K.,
FitzGerald M.G.,
Kodira C.D.,
Madan A.,
Qin S.,
Yang X.,
Abbasi N.,
Abouelleil A.,
Arachchi H.M.,
Baradarani L.,
Birditt B.,
Bloom S.,
Bloom T.,
Borowsky M.L.,
Burke J.,
Butler J.,
Cook A.,
DeArellano K.,
DeCaprio D.,
Dorris L. III,
Dors M.,
Eichler E.E.,
Engels R.,
Fahey J.,
Fleetwood P.,
Friedman C.,
Gearin G.,
Hall J.L.,
Hensley G.,
Johnson E.,
Jones C.,
Kamat A.,
Kaur A.,
Locke D.P.,
Madan A.,
Munson G.,
Jaffe D.B.,
Lui A.,
Macdonald P.,
Mauceli E.,
Naylor J.W.,
Nesbitt R.,
Nicol R.,
O'Leary S.B.,
Ratcliffe A.,
Rounsley S.,
She X.,
Sneddon K.M.B.,
Stewart S.,
Sougnez C.,
Stone S.M.,
Topham K.,
Vincent D.,
Wang S.,
Zimmer A.R.,
Birren B.W.,
Hood L.,
Lander E.S.,
Nusbaum C.;
"Analysis of the DNA sequence and duplication history of human chromosome 15.";
Nature 440:671-675(2006).
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 419-466, AND CHROMOSOMAL TRANSLOCATION WITH RARA.
PubMed=1312695 [NCBI, ExPASy, EBI, Israel, Japan]
Tong J.H.,
Dong S.,
Geng J.P.,
Huang W.,
Wang Z.Y.,
Sun G.L.,
Chen S.J.,
Chen Z.,
Larsen C.-J.,
Berger R.;
"Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants.";
Oncogene 7:311-316(1992).
|
[8]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 454-503, AND CHROMOSOMAL TRANSLOCATION WITH RARA.
PubMed=12691149 [NCBI, ExPASy, EBI, Israel, Japan]
Fujita K.,
Oba R.,
Harada H.,
Mori H.,
Niikura H.,
Isoyama K.,
Omine M.;
"Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation.";
Leuk. Lymphoma 44:111-115(2003).
|
[9]
|
SUMOYLATION AT LYS-65; LYS-160 AND LYS-490, MUTAGENESIS OF LYS-65; LYS-133; LYS-150; LYS-160 AND LYS-490, SUBCELLULAR LOCATION, AND FUNCTION.
DOI=10.1074/jbc.273.41.26675; PubMed=9756909 [NCBI, ExPASy, EBI, Israel, Japan]
Kamitani T.,
Kito K.,
Nguyen H.P.,
Wada H.,
Fukuda-Kamitani T.,
Yeh E.T.H.;
"Identification of three major sentrinization sites in PML.";
J. Biol. Chem. 273:26675-26682(1998).
|
[10]
|
INTERACTION WITH TRIM27.
PubMed=9570750 [NCBI, ExPASy, EBI, Israel, Japan]
Cao T.,
Duprez E.,
Borden K.L.,
Freemont P.S.,
Etkin L.D.;
"Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.";
J. Cell Sci. 111:1319-1329(1998).
|
[11]
|
INTERACTION WITH LASSA VIRUS Z PROTEIN.
PubMed=9420283 [NCBI, ExPASy, EBI, Israel, Japan]
Borden K.L.,
Campbell-Dwyer E.J.,
Salvato M.S.;
"An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.";
J. Virol. 72:758-766(1998).
|
[12]
|
INTERACTION WITH SIRT1.
DOI=10.1093/emboj/21.10.2383; PubMed=12006491 [NCBI, ExPASy, EBI, Israel, Japan]
Langley E.,
Pearson M.,
Faretta M.,
Bauer U.-M.,
Frye R.A.,
Minucci S.,
Pelicci P.G.,
Kouzarides T.;
"Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.";
EMBO J. 21:2383-2396(2002).
|
[13]
|
INTERACTION WITH TOPBP1.
DOI=10.1128/MCB.23.12.4247-4256.2003; PubMed=12773567 [NCBI, ExPASy, EBI, Israel, Japan]
Xu Z.-X.,
Timanova-Atanasova A.,
Zhao R.-X.,
Chang K.-S.;
"PML colocalizes with and stabilizes the DNA damage response protein TopBP1.";
Mol. Cell. Biol. 23:4247-4256(2003).
|
[14]
|
INTERACTION WITH SIAH1, AND DEGRADATION.
DOI=10.1074/jbc.M306407200; PubMed=14645235 [NCBI, ExPASy, EBI, Israel, Japan]
Fanelli M.,
Fantozzi A.,
De Luca P.,
Caprodossi S.,
Matsuzawa S.,
Lazar M.A.,
Pelicci P.G.,
Minucci S.;
"The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.";
J. Biol. Chem. 279:5374-5379(2004).
|
[15]
|
FUNCTION, INTERACTION WITH ELF4, AND SUBCELLULAR LOCATION.
DOI=10.1074/jbc.M312439200; PubMed=14976184 [NCBI, ExPASy, EBI, Israel, Japan]
Suico M.A.,
Yoshida H.,
Seki Y.,
Uchikawa T.,
Lu Z.,
Shuto T.,
Matsuzaki K.,
Nakao M.,
Li J.-D.,
Kai H.;
"Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein.";
J. Biol. Chem. 279:19091-19098(2004).
|
[16]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-403; SER-518; SER-527; SER-530; SER-535; SER-560; SER-561; SER-562 AND SER-565, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[17]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505 AND SER-512, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[18]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; THR-409; SER-518; SER-527 AND SER-530, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[19]
|
STRUCTURE BY NMR OF 49-104.
PubMed=7729428 [NCBI, ExPASy, EBI, Israel, Japan]
Borden K.L.B.,
Boddy M.N.,
Lally J.,
O'Reilly N.J.,
Martin S.,
Howe K.,
Solomon E.,
Freemont P.S.;
"The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML.";
EMBO J. 14:1532-1541(1995).
|
|